Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target

Barclays Initiates Ligand Pharmaceuticals at Overweight With $345 Price Target

MT newswireMT newswire2026/09/25 09:52
05:52 AM EDT, 09/25/2026 (MT Newswires) -- Ligand Pharmaceuticals (LGND) has an average rating of buy and mean price target of $353.09, according to analysts polled by FactSet. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Broadcom (AVGO.US) syndicate begins raising 60 billions USD to supply chip "ammunition" for companies like Anthropic

According to informed sources, Broadcom's Wall Street syndicate is initiating the raising of $60 billion in new financing to purchase artificial intelligence (AI) chips, with beneficiaries including Anthropic PBC and other companies.

智通财经•2026/10/02 06:21

A global bond market sell-off sweeps across the world, pushing the dollar to a 17-month high; the euro becomes the hardest-hit currency.

On Friday, the US dollar hovered near a 17-month high and is set to rise for the third consecutive week.

智通财经•2026/10/02 03:41